XML 49 R40.htm IDEA: XBRL DOCUMENT
v3.23.3

Share-Based Compensation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract] |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | Equity awards compensation expense recorded in the consolidated statements of operations was as follows:
| Nine Months Ended
| 2023 |  | 2022 |
| (in thousands)
Research and Development | (44,438) |  |  | (21,166) |  |
Sales and Operations | (15,240) |  |  | (9,695) |  |
General and Administrative | (16,675) |  |  | (11,733) |  |
Total equity awards compensation expense | (76,353) |  |  | (42,594) |  |
Tax benefit from equity awards compensation expense | 6,084 |  |  | 4,409 |  |
The breakdown of the equity award compensation expense by instrument type was as follows:
| Nine Months Ended
| 2023 |  | 2022 |
| (in thousands)
Share options | (80) |  |  | (47) |  |
Lock-up shares | (28,326) |  |  | (7,088) |  |
Restricted stock units / Performance stock units | (46,519) |  |  | (33,976) |  |
Non-employee warrants | (1,428) |  |  | (1,483) |  |
Total equity awards compensation expense | (76,353) |  |  | (42,594) |  |
Tax benefit from equity awards compensation expense | 6,084 |  |  | 4,409 |  |
A detailed description of each instrument type is provided below.
Schedule of Stock Options Roll Forward |
| Options Outstanding
Number of Shares Underlying Outstanding Options |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Outstanding as of December 31, 2022 | 372,329 |  |  |  |  |  |  |
Options granted | — |  |  |  |  |  |  |
Options exercised | (41,417) |  |  |  |  |  |  |
Options forfeited | (3,973) |  |  |  |  |  |  |
Options canceled | — |  |  |  |  |  |  |
Options expired | (1,861) |  |  |  |  |  |  |
Outstanding as of September 30, 2023 | 325,078 |  |  | € | 20.88 |  |  | 4.37 |  | € | 11.46 |
Vested and exercisable as of September 30, 2023 | 301,611 |  |  |  |  |  |  |
Schedule of Nonvested Share Activity |
| Shares |  | Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2022 | 2,960,243 |  |  | — |
Granted | — |  |  | — |
Vested | (1,006,482) |  |  | — |
Forfeited | — |  |  | — |
Outstanding as of September 30, 2023 | 1,953,761 |  |  | € | 23.94 |
Schedule of Nonvested Restricted Stock Units Activity |
| Shares (RSU) |  | Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2022 | 5,349,955 |  |  | — |
Granted | 1,575,851 |  |  | — |
Vested | (1,116,711) |  |  | — |
Forfeited | (340,383) |  |  | — |
Outstanding as of September 30, 2023 | 5,468,712 |  |  | € | 26.2 |
Share-Based Payment Arrangement, Performance Shares, Activity |
| Shares (PSU) |  | Weighted-Average Grant date Fair Value Per Share
Outstanding as of December 31, 2022 | 522,467 |  |  | — |
Granted | 356,402 |  |  | — |
Vested | (173,092) |  |  | — |
Forfeited | — |  |  | — |
Outstanding as of September 30, 2023 | 705,777 |  |  | € | 27.94 |
Schedule of Stockholders' Equity Note, Warrants or Rights |
| Shares |  | Weighted-Average Grant date Fair Value Per Share |  | Weighted-Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Outstanding as of December 31, 2022 | 302,775 |  |  |  |  |  |  |
Granted | — |  |  |  |  |  |  |
Exercised | (58,318) |  |  |  |  |  |  |
Canceled | — |  |  |  |  |  |  |
Expired | — |  |  |  |  |  |  |
Outstanding as of September 30, 2023 | 244,457 |  |  | € | 17.65 |  |  | 4.73 |  | € | 12.98 |
Vested and exercisable - September 30, 2023 | 237,852 |  |  |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References No definition available. + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration